The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.80
Bid: 76.80
Ask: 80.60
Change: -2.55 (-3.21%)
Spread: 3.80 (4.948%)
Open: 77.80
High: 78.10
Low: 76.80
Prev. Close: 79.35
KYGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kerry to acquire Lactase Enzymes Business

12 Dec 2023 16:13

RNS Number : 5363W
Kerry Group PLC
12 December 2023

12 December 2023

LEI: 635400TLVVBNXLFHWC59

KERRY GROUP

Kerry to acquire Lactase Enzymes Business

Kerry Group plc ("Kerry"), the global taste & nutrition company, announces it has entered into a definitive agreement to acquire part of the global lactase enzyme business of Chr. Hansen Holding A/S ("Chr. Hansen") and Novozymes A/S ("Novozymes") (together the "Lactase Enzymes Business") on a carve out basis¹. This acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger approval process.

The Lactase Enzymes Business which includes NOLA® Products, further enhances Kerry's biotechnology solutions capability following the acquisitions of c-LEcta and Enmex². This acquisition adds enzyme technology which helps create lactose-free and sugar reduced dairy products, while preserving their authentic clean taste. Global demand for lactase is being driven by increased awareness of lactose intolerance, while many consumers are also choosing lactose-free for lifestyle and health reasons.

The Lactase Enzymes Business had attributable revenue of approximately ?40m in 2022 with sales in over 50 countries. Total consideration is ?150m subject to routine closing adjustments, with the acquisition expected to close in the first half of 2024.

¹ Acquisition comprises certain trade and assets of Chr. Hansen's global lactase enzyme business and 100% of the share capital of Nuocheng Trillion Food (Tianjin) Co., Ltd, a Chinese subsidiary of Novozymes.

² Acquisition of c-LEcta GmbH completed in March 2022 and Enmex S.A. de C.V. in December 2021.

ENDS

About Kerry

Kerry is a world leading taste and nutrition partner for the food, beverage and pharmaceutical markets. We innovate with our customers to create great tasting products, with improved nutrition and functionality, while ensuring better impact for the planet. Our leading consumer insights, global RD&A team of 1,100+ food scientists and extensive global footprint enable us to solve our customers' complex challenges with differentiated solutions. At Kerry, we are driven to be our customers' most valued partner, creating a world of sustainable nutrition, and to reach over 2 billion consumers with sustainable nutrition solutions by 2030. For more information, visit www.kerry.com.

CONTACT INFORMATION

Investor Relations

Marguerite Larkin, Chief Financial Officer

+353 66 7182292 | investorrelations@kerry.ie

William Lynch, Head of Investor Relations

+353 66 7182292 | investorrelations@kerry.ie

Media

Catherine Keogh, Chief Corporate Affairs & Brand Officer

+353 45 930188 | corpaffairs@kerry.com

Website

www.kerry.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQBLBDDDBBDGXD
Date   Source Headline
4th May 20177:00 amRNSAGM: Interim Management Statement
2nd May 201711:54 amRNSVoting Rights and Share Capital
4th Apr 20175:00 pmRNSAnnual Report and AGM Notice
3rd Apr 20173:05 pmRNSVoting Rights and Share Capital
6th Mar 20174:56 pmRNSDirector/PDMR Shareholding
6th Mar 20174:54 pmRNSDirector/PDMR Shareholding
6th Mar 20174:52 pmRNSDirector/PDMR Shareholding
6th Mar 20174:50 pmRNSDirector/PDMR Shareholding
1st Mar 201712:55 pmRNSVoting Rights and Share Capital
21st Feb 20177:00 amRNSPreliminary Statement of Results
1st Feb 201710:26 amRNSTotal Voting Rights
30th Jan 201710:22 amRNSHolding(s) in Company
30th Jan 201710:18 amRNSHolding(s) in Company
3rd Jan 20175:27 pmRNSBlock Listing Six Monthly Return
3rd Jan 20174:06 pmRNSDirectorate Change
3rd Jan 201710:11 amRNSVoting Rights and Share Capital
14th Dec 20169:58 amRNSHolding(s) in Company
1st Dec 20163:31 pmRNSVoting Rights and Share Capital
3rd Nov 20169:31 amRNSVoting Rights and Share Capital
2nd Nov 20167:01 amRNSQ3 2016 Interim Management Statement
3rd Oct 201611:09 amRNSVoting Rights and Share Capital
1st Sep 20162:30 pmRNSVoting Rights and Share Capital
4th Aug 20167:00 amRNSHalf-year Report
2nd Aug 201612:19 pmRNSVoting Rights and Share Capital
7th Jul 201611:40 amRNSBlock Listing Six Monthly Return
4th Jul 201612:56 pmRNSVoting Rights and Share Capital
1st Jun 201611:15 amRNSVoting Rights and Share Capital
4th May 20169:40 amRNSVoting Rights and Share Capital
28th Apr 20162:29 pmRNSResult of AGM
27th Apr 20167:01 amRNSKerry Group AGM: Interim Management Statement
1st Apr 20162:36 pmRNSVoting Rights and Share Capital
30th Mar 20169:35 amRNSAnnual Financial Report
14th Mar 20165:02 pmRNSDirector/PDMR Shareholding
14th Mar 20165:00 pmRNSDirector/PDMR Shareholding
14th Mar 20164:58 pmRNSDirector/PDMR Shareholding
14th Mar 20164:56 pmRNSDirector/PDMR Shareholding
14th Mar 20164:54 pmRNSDirector/PDMR Shareholding
14th Mar 20164:51 pmRNSDirector/PDMR Shareholding
1st Mar 201611:23 amRNSVoting Rights and Share Capital
1st Mar 201610:12 amRNSBlocklisting Six Monthly Return
23rd Feb 20167:00 amRNSPreliminary Statement of Results
1st Feb 20163:17 pmRNSVoting Rights and Share Capital
18th Jan 20164:52 pmRNSNotification of Major Holdings
4th Jan 20162:46 pmRNSVoting Rights and Share Capital
10th Dec 20155:38 pmRNSNotification of Major Interest in Shares
1st Dec 201511:56 amRNSVoting Rights and Share Capital
3rd Nov 20157:04 amRNSKerry Group Q3 Interim Management Statement
2nd Nov 20152:32 pmRNSVoting Rights and Share Capital
19th Oct 201512:08 pmRNSNotification of Major Interest in Shares
15th Oct 20151:10 pmRNSKerry Group announces US$735m acquisitions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.